EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Caribou Biosciences, Inc. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 78.39. In total, the insiders bought 4 096 718 and sold 409 985 CRBU shares in the last 100 trades.

Insider Power

(Last 100 transactions)
78.39
Buy 4 096 718 Shares
Sell 409 985 Shares

Historical Insider Trades

Date Type Action Person Amount
Feb 20, 2024 Option to purchase Common Stock Buy O'byrne Jason 153 000
Feb 20, 2024 Common Stock Buy O'byrne Jason 33 000
Feb 20, 2024 Common Stock Buy Mcclung Barbara G 33 000
Feb 20, 2024 Option to purchase Common Stock Buy Mcclung Barbara G 153 000
Feb 20, 2024 Option to purchase Common Stock Buy Khan Ruhi Ahmad 153 000
Feb 20, 2024 Common Stock Buy Khan Ruhi Ahmad 33 000
Feb 20, 2024 Option to purchase Common Stock Buy Haurwitz Rachel E. 546 950
Feb 20, 2024 Common Stock Buy Haurwitz Rachel E. 118 700
Feb 20, 2024 Common Stock Buy Kanner Steven 33 000
Feb 20, 2024 Option to purchase Common Stock Buy Kanner Steven 153 000
Feb 20, 2024 Option to purchase Common Stock Buy Zheng Ran 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Whiting Nancy 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Sacks Natalie 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Richardson-heron Dara 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Johnson David Lee 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Guggenhime Andrew 39 500
Feb 20, 2024 Option to purchase Common Stock Buy Braunstein Scott 39 500
Feb 06, 2024 Common Stock Buy Kanner Steven 30 577
Feb 06, 2024 Option to purchase Common Stock Sell Kanner Steven 30 577
Jan 08, 2024 Option to purchase Common Stock Buy Kelly Timothy P 300 000
Jan 01, 2024 Buy Kelly Timothy P 0
Jan 01, 2024 Buy Kelly Timothy P 0
Jun 08, 2023 Option to purchase Common Stock Sell Haurwitz Rachel E. 10 000
Jun 08, 2023 Common Stock Buy Haurwitz Rachel E. 10 000
Mar 20, 2023 Option to purchase Common Stock Sell Haurwitz Rachel E. 10 000
Click to get the best stock tips daily for free!

About Caribou Biosciences, Inc.

Caribou Biosciences. Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic ... CRBU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT